New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity

doi:10.1007/s13659-026-00616-0

Abstract

Abstract: Twelve new sesquiterpenoids, sanguisorbaols A-L (1-12), along with twenty-five known compounds (13-37), were isolated from the roots of Sanguisorba officinalis. Structures were determined through comprehensive analysis of HRESIMS, 1D and 2D NMR spectroscopic data, ECD and NMR calculations, and X-ray crystallographic analysis. Among them, compounds 1-6 were identified as new patchoulol-type sesquiterpenoids bearing hydroxyl groups at different positions, the further structural elucidation revealed that compounds 5 and 6 are nor-patchoulol-type sesquiterpenoids due to the absence of the C-11 carbon atom. Compounds 7-11 were characterized as guaiane-type sesquiterpenoids incorporating a [5,7]-bicyclic framework, among which 7 and 8 constitute a pair of C-11 epimers. Notably, compound 12 possesses a rare bicyclo[4.3.1]decane core scaffold. All the patchoulol-type sesquiterpenoids reported here were obtained for the first time from the genus Sanguisorba, and a plausible biosynthetic pathway was proposed. Furthermore, the anti-melanogenic bioactivity of all isolates was assessed using IBMX-stimulated B16F10 melanoma cells. Compounds 3-5, 8-10, 12-14, 17, 19, 21, 22, 25-27, 29, 31, 32 and 34 demonstrated significant inhibitory activity against melanogenesis at concentrations ranging from 6.25 to 50 μM. These results highlighted the potential of S. officinalis as a natural anti-melanogenesis agent for skin-whitening or for the treatment of hyperpigmentation disorders.

Key words: Sanguisorba officinalis, Patchoulol-type sesquiterpenoids, Guaiane-type sesquiterpenoids, Anti-melanogenic activity, Whitening agents

摘要： Twelve new sesquiterpenoids, sanguisorbaols A-L (1-12), along with twenty-five known compounds (13-37), were isolated from the roots of Sanguisorba officinalis. Structures were determined through comprehensive analysis of HRESIMS, 1D and 2D NMR spectroscopic data, ECD and NMR calculations, and X-ray crystallographic analysis. Among them, compounds 1-6 were identified as new patchoulol-type sesquiterpenoids bearing hydroxyl groups at different positions, the further structural elucidation revealed that compounds 5 and 6 are nor-patchoulol-type sesquiterpenoids due to the absence of the C-11 carbon atom. Compounds 7-11 were characterized as guaiane-type sesquiterpenoids incorporating a [5,7]-bicyclic framework, among which 7 and 8 constitute a pair of C-11 epimers. Notably, compound 12 possesses a rare bicyclo[4.3.1]decane core scaffold. All the patchoulol-type sesquiterpenoids reported here were obtained for the first time from the genus Sanguisorba, and a plausible biosynthetic pathway was proposed. Furthermore, the anti-melanogenic bioactivity of all isolates was assessed using IBMX-stimulated B16F10 melanoma cells. Compounds 3-5 , 8-10 , 12-14 , 17 , 19 , 21 , 22 , 25-27 , 29 , 31 , 32 and 34 demonstrated significant inhibitory activity against melanogenesis at concentrations ranging from 6.25 to 50 μM. These results highlighted the potential of S. officinalis as a natural anti-melanogenesis agent for skin-whitening or for the treatment of hyperpigmentation disorders.

关键词: Sanguisorba officinalis, Patchoulol-type sesquiterpenoids, Guaiane-type sesquiterpenoids, Anti-melanogenic activity, Whitening agents

Long-Long Wu, Jia-Rui Wu, Kai-Xian Chen, Liu-Qiang Zhang, Yi-Ming Li. New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity[J]. Natural Products and Bioprospecting, 2026, 16(5): 63-63.

References

[1] Sun W, Zhang Z, Liu X, Zhang S, He L, Wang Z, et al. Terpene glycosides from the roots of Sanguisorba officinalis L. and their hemostatic activities. Molecules. 2012;17(7):7629–36. https://doi.org/10.3390/molecules17077629.
[2] Zhao Z, He X, Zhang Q, Wei X, Huang L, Fang JC, et al. Traditional uses, chemical constituents and biological activities of plants from the genus Sanguisorba L. Am J Chin Med. 2017;45(2):199–224. https://doi.org/10.1142/S0192415X17500136.
[3] Wang L, Li H, Shen X, Zeng J, Yue L, Lin J, et al. Elucidation of the molecular mechanism of Sanguisorba officinalis L. against leukopenia based on network pharmacology. Biomed Pharmacother. 2020;132:110934. https://doi.org/10.1016/j.biopha.2020.110934.
[4] Cheng DL, Cao XP. Pomolic acid derivatives from the root of Sanguisorba officinalis. Phytochemistry. 1992;31(4):1317–20. https://doi.org/10.1016/0031-9422(92)80499-5.
[5] Wang LN, Qin LL, He JL, Li XH, Cao ZX, Gu YC, et al. Aryl-tetralin-type lignan isolated from Sanguisorba officinalis. J Asian Nat Prod Res. 2019;21(10):999–1004. https://doi.org/10.1080/10286020.2018.1487957.
[6] Wu LL, Xu HY, Zhang LQ, Li YM. Research progress on chemical constituents and pharmacological activities of Sanguisorba officinalis. World Sci Technol/Mod Tradit Chin Med Mater Med. 2022;24(01):360–78. https://doi.org/10.11842/wst.20210302005.
[7] Gao X, Wu J, Zou W, Dai Y. Two ellagic acids isolated from roots of Sanguisorba officinalis L. promote hematopoietic progenitor cell proliferation and megakaryocyte differentiation. Molecules. 2014;19(4):5448–58. https://doi.org/10.3390/molecules19045448.
[8] Yu T, Lee YJ, Yang HM, Han S, Kim JH, Lee Y, et al. Inhibitory effect of Sanguisorba officinalis ethanol extract on NO and PGE2 production is mediated by suppression of NF-κB and AP-1 activation signaling cascade. J Ethnopharmacol. 2011;134(1):11–7. https://doi.org/10.1016/j.jep.2010.08.060.
[9] Su XD, Guo RH, Li HX, Ma JY, Kim YR, Kim YH, et al. Anti-allergic inflammatory components from Sanguisorba officinalis L. Bioorg Med Chem Lett. 2018;28(12):2210–6. https://doi.org/10.1016/j.bmcl.2018.04.033.
[10] Yasueda A, Kayama H, Murohashi M, Nishimura J, Wakame K, Komatsu K, et al. Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages. Sci Rep. 2020;10(1):9972. https://doi.org/10.1038/s41598-020-65306-4.
[11] Zhang S, Liu X, Zhang ZL, He L, Wang Z, Wang GS. Isolation and identification of the phenolic compounds from the roots of Sanguisorba officinalis L. and their antioxidant activities. Molecules. 2012;17(12):13917–22. https://doi.org/10.3390/molecules171213917.
[12] Wang Z, Loo WT, Wang N, Chow LW, Wang D, Han F, et al. Effect of Sanguisorba officinalis L. on breast cancer growth and angiogenesis. Expert Opin Ther Targets. 2012;16(1):S79–89. https://doi.org/10.1517/14728222.2011.642371.
[13] Zhu H, Chen G, Chen S, Wang Q, Wan L, Jian S. Characterization of polyphenolic constituents from Sanguisorba officinalis L. and its antibacterial activity. Eur Food Res Technol. 2019;245(7):1487–98. https://doi.org/10.1007/s00217-019-03276-2.
[14] Son DJ, Hwang SY, Kim MH, Park UK, Kim BS. Anti-diabetic and hepato-renal protective effects of Ziyuglycoside II methyl ester in type 2 diabetic mice. Nutrients. 2015;7(7):5469–83. https://doi.org/10.3390/nu7075232.
[15] Sea JK, Do CY, Jung MH, Jung SJ, Kang SY. In vivo antiviral activitiy of Sanguisorba officinalis roots against viral hemorrhagic septicemia virus in olive flounder Paralichthys olivaceus. Planta Med. 2015;81(16):45. https://doi.org/10.1055/s-0035-1565669.
[16] Yang JH, Hwang YH, Gu MJ, Cho WK, Ma JY. Ethanol extracts of Sanguisorba officinalis L. suppress TNF-α/IFN-γ-induced pro-inflammatory chemokine production in HaCaT cells. Phytomedicine. 2015;22(14):1262–8. https://doi.org/10.1016/j.phymed.2015.09.006.
[17] Zhang H, Chen J, Cen Y. Burn wound healing potential of a polysaccharide from Sanguisorba officinalis L. in mice. Int J Biol Macromol. 2018;112:862–7. https://doi.org/10.1016/j.ijbiomac.2018.01.214.
[18] Negm WA, El-Kadem AH, Elekhnawy E, Attallah NGM, Al-Hamoud GA, El-Masry TA, et al. Wound-healing potential of rhoifolin-rich fraction isolated from Sanguisorba officinalis roots supported by enhancing re-epithelization, angiogenesis, anti-inflammatory, and antimicrobial effects. Pharmaceuticals. 2022;15(2):178. https://doi.org/10.3390/ph15020178.
[19] Muzykiewicz-Szymańska A, Nowak A, Kucharska E, Cybulska K, Klimowicz A, Kucharski A. Sanguisorba officinalis L. ethanolic extracts and essential oil - chemical composition, antioxidant potential, antibacterial activity, and ex vivo skin permeation study. Front Pharmacol. 2024;15:1390551. https://doi.org/10.3389/fphar.2024.1390551.
[20] Li X, Chen L, Wang H, Li Y, Wu H, Guo F. Germacrone, isolated from Curcuma wenyujin, inhibits melanin synthesis through the regulation of the MAPK signaling pathway. J Nat Med. 2024;78(4):863–75. https://doi.org/10.1007/s11418-024-01818-x.
[21] Zhou L, Xu M, Yang C, Wang Y, Zhang Y. New patchoulol-type sesquiterpenoids from Pogostemon cablin. Helv Chim Acta. 2011;94(2):218–23. https://doi.org/10.1002/hlca.201000151.
[22] Xu F, Liao K, Liu Y, Zhang Z, Guo D, Su Z, et al. Biotransformation of patchoulol by Cunninghamella echinulata var. elegans. Fitoterapia. 2016;109:201–5. https://doi.org/10.1016/j.fitote.2016.01.001.
[23] Zhou X, Zhou X, Ma J, Wu J, Li H, Li R, et al. Anti-influenza patchoulol-type sesquiterpenoids from Pogostemon cablin. Phytochem Lett. 2022;48:34–9. https://doi.org/10.1016/j.phytol.2022.01.010.
[24] Li S, Feng Y, Zhou Y, Liao C, Su L, Liu D, et al. Pogocablenes A-O, fifteen undescribed sesquiterpenoids with structural diversity from Pogostemon cablin. Phytochemistry. 2023;214:113829. https://doi.org/10.1016/j.phytochem.2023.113829.
[25] Wei H, Xu Y, Espinosa-Artiles P, Liu MX, Luo J, U Ren JM, et al. Sesquiterpenes and other constituents of Xylaria sp. NC1214, a fungal endophyte of the moss Hypnum sp. Phytochemistry. 2015;118:102–8. https://doi.org/10.1016/j.phytochem.2015.08.010.
[26] Pan J, Su J, Liu Y, Deng B, Hu Z, Wu J, et al. Stelleranoids A–M, guaiane-type sesquiterpenoids based on [5,7] bicyclic system from Stellera chamaejasme and their cytotoxic activity. Bioorg Chem. 2021;115:105251. https://doi.org/10.1016/j.bioorg.2021.105251.
[27] Sutthivaiyakit S, Mongkolvisut W, Prabpai S, Kongsaeree P. Diterpenes, sesquiterpenes, and a sesquiterpene-coumarin conjugate from Jatropha integerrima. J Nat Prod. 2009;72(11):2024–7. https://doi.org/10.1021/np900342b.
[28] Xiong J, Wang L, Qian J, Wang P, Wang X, Ma G, et al. Structurally diverse sesquiterpenoids from the endangered ornamental plant Michelia shiluensis. J Nat Prod. 2018;81(10):2195–204. https://doi.org/10.1021/acs.jnatprod.8b00386.
[29] Aleu J, Hanson JR, Galán RH, Collado IG. Biotransformation of the fungistatic sesquiterpenoid patchoulol by Botrytis cinerea. J Nat Prod. 1999;62(3):437–40. https://doi.org/10.1021/np980416e.
[30] Barton DHR, Bel?il J, Billion A, Boivion J, Lallemand J, Mergui S. Functionalisation of saturated hydrocarbons. Part 9. Oxidation of patchouli alcohol by the “gif system”: isolation and organoleptic properties of three new ketonic derivatives. Helv Chim Acta. 1987;70(2):273–80. https://doi.org/10.1002/hlca.19870700202.
[31] Li F, Li C, Ma J, Yang J, Chen H, Liu X, et al. Four new sesquiterpenes from the stems of Pogostemon cablin. Fitoterapia. 2013;86:183–7. https://doi.org/10.1016/j.fitote.2013.03.010.
[32] Huang A, Sefton MA, Sumby CJ, Tiekink ERT, Taylor DK. Mechanistic studies on the autoxidation of α-guaiene: structural diversity of the sesquiterpenoid downstream products. J Nat Prod. 2015;78(1):131–45. https://doi.org/10.1021/np500819f.
[33] Wu S, He J, Li X, Huang R, Song F, Chen Y, et al. Guaiane sesquiterpenes and isopimarane diterpenes from an endophytic fungus Xylaria sp. Phytochemistry. 2014;105:197–204. https://doi.org/10.1016/j.phytochem.2014.04.016.
[34] Heymann H, Tezuka Y, Kikuchi T, Supriyatna S. Constituents of Sindora sumatrana MIQ. I. isolation and NMR spectral analysis of sesquiteroenes from the dried pods. Chem Pharm Bull. 1994;42(1):138–46. https://doi.org/10.1248/cpb.42.138.
[35] Nhiem NX, Van Kiem P, Van Minh C, Hoai NT, Duc HV, Tai BH, et al. Anti-influenza sesquiterpene from the roots of Reynoutria japonica. Nat Prod Commun. 2014;9(3):315–8. https://doi.org/10.1177/1934578x1400900308.
[36] Fraga BM, Díaz CE, Amador LJ, Reina M, Santana O, González-Coloma A. Bioactive compounds from transformed root cultures and aerial parts of Bethencourtia hermosae. Phytochemistry. 2014;108:220–8. https://doi.org/10.1016/j.phytochem.2014.09.010.
[37] Stakanovs G, Blazevica A, Belyakov S, Rasina D, Jirgensons A. Semisynthesis of Linariophyllenes A–C and Rumphellolide H, structure revisions and proposed biosynthesis pathways. J Nat Prod. 2023;86(10):2368–78. https://doi.org/10.1021/acs.jnatprod.3c00574.
[38] Fan XN, Lin S, Zhu CG, Hu JF, Liu Y, Chen XG, et al. Terpenoids of Heteroplexis micocephala and their bioactivities. Chin J Chin Mater Med. 2010;35(3):315–22. https://doi.org/10.4268/cjcmm20100313.
[39] Ma G, Chen K, Zhang L, Li Y. Advance in biological activities of natural guaiane-type sesquiterpenes. Med Chem Res. 2019;28(9):1339–58. https://doi.org/10.1007/s00044-019-02385-7.
[40] Ren Q, Zhao W, Shi S, Han F, Zhang Y, Liu Q, et al. Guaiane-type sesquiterpenoids from the roots of Daphne genkwa and evaluation of their neuroprotective effects. J Nat Prod. 2019;82(6):1510–7. https://doi.org/10.1021/acs.jnatprod.8b01049.
[41] Cheng Z, Hou Z, Ren J, Zhang D, Lin B, Huang X, et al. Guaiane-type sesquiterpenoids from the roots of Stellera chamaejasme L. and their neuroprotective activities. Phytochemistry. 2021;183:112628. https://doi.org/10.1016/j.phytochem.2020.112628.
[42] Adekenov SM. Sesquiterpene lactones with unusual structure. Their biogenesis and biological activity. Fitoterapia. 2017;121:16–30. https://doi.org/10.1016/j.fitote.2017.05.017.
[43] Ding L, Goerls H, Dornblut K, Lin W, Maier A, Fiebig H, et al. Bacaryolanes A–C, rare bacterial caryolanes from a Mangrove endophyte. J Nat Prod. 2015;78(12):2963–7. https://doi.org/10.1021/acs.jnatprod.5b00674.
[44] Ninomiya D, Nagasawa S, Iwabuchi Y. Enantiocontrolled access to an intermediate for highly functionalized clovane-type terpenoids: formal synthesis of Rumphellclovane E. Org Lett. 2022;24(41):7572–6. https://doi.org/10.1021/acs.orglett.2c02960.
[45] Struwe H, Schr?dter F, Spinck H, Kirschning A. Sesquiterpene backbones generated by sesquiterpene cyclases: formation ofiso-caryolan-1-ol and an isoclovane. Org Lett. 2023;25(48):8575–9. https://doi.org/10.1021/acs.orglett.3c03383.
[46] Wu L, Liu J, Chen K, Zhang L, Li Y. Triterpenoids from the roots of Sanguisorba officinalis and their Nrf2 stimulation activity. Phytochemistry. 2023;214:113803. https://doi.org/10.1016/j.phytochem.2023.113803.
[47] Zhao P, Lou L, Xin B, Li Z, Guo R, Zhou W, et al. Rapid determination of the relative configuration of diverse 8,4′-oxyneolignans by NMR analysis: retrospective studies, improvement and structural revision. Phytochemistry. 2023;214:113801. https://doi.org/10.1016/j.phytochem.2023.113801.
[48] Pinto BNS, Teixeira MG, Alvarenga ES. Synthesis and structural elucidation of a phthalide analog using NMR analysis and DFT calculations. Magn Reson Chem. 2020;58(6):559–65. https://doi.org/10.1002/mrc.4976.
[49] Smith SG, Goodman JM. Assigning stereochemistry to single diastereoisomers by GIAO NMR calculation: the DP4 probability. J Am Chem Soc. 2010;132(37):12946–59. https://doi.org/10.1021/ja105035r.
[50] Willoughby PH, Jansma MJ, Hoye TR. A guide to small-molecule structure assignment through computation of (¹H and ¹³C) NMR chemical shifts. Nat Protoc. 2014;9(3):643–60. https://doi.org/10.1038/nprot.2014.042.
[51] Zhuang Y, Yang F, Menon A, Song JM, Espinoza RV, Schultz PJ, et al. An ECD and NMR/DP4+ computational pipeline for structure revision and elucidation of diphenazine-based natural products. J Nat Prod. 2023;86(7):1801–14. https://doi.org/10.1021/acs.jnatprod.3c00306.
[52] Jiang R, Xu X, Wang K, Yang X, Bi Y, Yan Y, et al. Ethyl acetate extract from Panax ginseng C.A. Meyer and its main constituents inhibit α-melanocyte-stimulating hormone-induced melanogenesis by suppressing oxidative stress in B16 mouse melanoma cells. J Ethnopharmacol. 2017;208:149–56. https://doi.org/10.1016/j.jep.2017.07.004.
[53] Lv J, Yang Y, Jia B, Li S, Zhang X, Gao R. The inhibitory effect of curcumin derivative J147 on melanogenesis and melanosome transport by facilitating ERK-mediated MITF degradation. Front Pharmacol. 2021;12:783730. https://doi.org/10.3389/fphar.2021.783730.